R. Boellaard, M. O'Doherty, W. Weber, F. Mottaghy, M. Lonsdale, S. Stroobants, W. Oyen, J. Kotzerke, O. Hoekstra, J. Pruim, P. Marsden, K. Tatsch, C. Hoekstra, E. Visser, B. Arends, F. Verzijlbergen, J. Zijlstra, E. Comans, A. Lammertsma, A. Paans, A. Willemsen, T. Beyer, A. Bockisch, C. Schaefer-Prokop, D. Delbeke, R. Baum, A. Chiti, B. Krause
2009.11.14EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
tlooto Summary
This guideline will address general information about [18F]-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET/CT) and is provided to help the physician and physicist to assist to carrying out, interpret, and document quantitative FDG PET/CT examinations.
Abstract
The aim of this guideline is to provide a minimum standard for the acquisition and interpretation of PET and PET/CT scans with [18F]-fluorodeoxyglucose (FDG). This guideline will therefore address general information about [18F]-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET/CT) and is provided to help the physician and physicist to assist to carrying out, interpret, and document quantitative FDG PET/CT examinations, but will concentrate on the optimisation of diagnostic quality and quantitative information.
Citation format
BOELLAARD, R., et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: Version 1.0. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 37: 181–200.